Catalyst Event
InnoCare Pharma Ltd (9969) · Earnings Release
From Akros SCHK HK-U.S. Biotech Index (ASHUBIO)
4/23/2026, 12:00:00 AM
Announced Q1 2026 results on 2026-04-23, with revenue of CNY 528.6 million (+38.7% YoY) and net profit of CNY 105.8 million (+489% YoY). High importance estimated due to the significant profit surge likely resulting in ≥10% price impact.
Korean Translation
2026년 4월 23일, 2026년 1분기 실적 발표를 통해 매출 5억 2,860만 위안(전년 대비 38.7% 증가) 및 순이익 1억 580만 위안(전년 대비 489% 증가)를 기록함. 순이익의 대폭적인 증가로 10% 이상의 주가 변동이 예상되어 중요도를 'High'로 평가함.
Related Recent Events
WuXi Biologics (Cayman) Inc (2269) · Other
The U.S. Office of Management and Budget (OMB) is scheduled to publish a full list of 'biotechnology companies of concern' (BCCs) by December 18, 2026, under the BIOSECURE Act; High importance is justified by the potential for severe regulatory risk causing a >10% price impact scheduled.
12/18/2026, 12:00:00 AM
WuXi AppTec Co Ltd (2359) · Other
Ex-dividend date on May 13, 2026, for the 2025 final cash dividend of RMB 1.57927 per share (RMB 15.7927 per 10 shares); low impact estimated as price typically adjusts by the dividend amount, scheduled.
5/13/2026, 12:00:00 AM
Gilead Sciences Inc (GILD) · Earnings Release
Q1 2026 earnings release is scheduled for 2026-05-07. This event is estimated to have a high price impact as quarterly results often drive significant market volatility scheduled.
5/7/2026, 12:00:00 AM
Kenvue Inc (KVUE) · Earnings Release
Kenvue will announce its first quarter 2026 financial results before the market opens on May 7, 2026. Based on historical earnings volatility, a 5% price impact is expected.
5/7/2026, 12:00:00 AM
Pfizer Inc (PFE) · Earnings Release
Pfizer is scheduled to release its Q1 2026 earnings results before the market opens on May 5, 2026, scheduled.
5/5/2026, 12:00:00 AM
Vertex Pharmaceuticals Inc (VRTX) · Earnings Release
Vertex Pharmaceuticals is scheduled to announce its first-quarter 2026 financial results after the market closes on May 4, 2026. This earnings release is estimated to have a >=5% price impact, scheduled
5/4/2026, 12:00:00 AM